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In medical practice, knowledge of the prognosis of the disease
being treated is important both for the clinician and the
patient. Unlike physicians of old, who depended solely on their
own personal knowledge and experience accumulated from
careful and systematic observations of their patients, modern
physicians are fortunate in having easy access to the large store
of common medical knowledge, particularly pathophysiology
and therapeutics, in addition to the personal knowledge and
experience gained in practice, on which to base their disease
prognostication and treatment decisions. Often, however, this
knowledge is found to be inadequate or imprecise in helping a
physician predict, to a reasonable degree of certainty, a patient’s
prognosis, and to use this knowledge as a guide in making
therapeutic decisions. The convergence of modern databases,
statistical methods and computing capabilities, in making
possible the analysis of prognostic predictors, would appear to
fulfill this need. This in essence combines, quantitatively, the
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experience of many physicians and their observations on a
particular disease. By so doing, the influence of the pecu-
liarities in particular case or cases experienced by any one
physician would be diminished; instead, the commonality of
many similar cases would be strengthened, resulting in a
greater degree of certainty.
Myocardial infarction (MI) is a disease in which the
development of more precise estimates of risk and prognosis
is desirable. It affects many people. Coronary atherosclero-
sis, which forms the underlying basis for acute MI, is a
chronic disease that can result in serious and fatal outcomes,
both in the acute phase and subsequently. It is also a disease
for which efficacious therapies have been developed during
the last two decades. This further amplifies the need for
prognostic prediction on which to form an understanding of
future expectations and to base therapeutic and other
management decisions so as to reduce the associated short-
and long-term morbidity and mortality.
In risk stratification studies, the presence of a variable
such as the presence of myocardial ischemia or poor left
ventricular function has been usefully employed to guide
decisions involving management and interventions to re-
duce risk for future events (1–4). In the acute phase of MI,
studies have identified adverse prognostic variables, and
algorithms have been produced using this information in
order to aid decision making and improve patient outcomes
(5,6). Other studies about survivors of acute MI, based on
patients enrolled in clinical trials or on regional or local
populations, can provide useful insights into the evolution of
the MI and the underlying coronary artery disease and guide
practice decisions regarding secondary prevention (7–9). Of
the many risk prediction and stratification studies carried
out, most were done in a narrowly focused or nonsystematic
manner, using information available in a particular data set.
This can limit the relevance of such studies to other
populations. Also, though the information from these stud-
ies can be judged to be generally relevant to all patients with
MI, the prognostic predictors reported in most of these
studies are more limited in their applicability to special
populations, such as the elderly and women.
In this context, the analysis by Krumholz et al. (10) in this
issue of the Journal can fill a large information gap on the
elderly, focusing on the important co-morbidities and dis-
ease severity in elderly survivors of acute MI. The data from
the U.S. nationwide Cooperative Cardiovascular Project
(CCP), which encompassed a wide range of individuals over
a wide geographical distribution, have proven to be ex-
tremely useful (6,10). The CCP database, combining both
information extracted from individual patient charts and
administrative databases, includes data on a large number of
individuals age 65 years or older that are included in the
Krumholz et al. (10) study. There are a large number of
variables, both clinical and laboratory, that can be important
for the purpose of this analysis. By using the data from over
100,000 individuals who have survived the hospitalization
for the index MI, one can be impressed with the statistical
power that this database can confer on the analysis.
The process for arriving at a model for prediction of
one-year mortality from a set of variables encompasses three
components: selection of predictors, parameter estimation
and assessment of model performance. In the present
analysis, Cox regression models were appropriately used to
identify the variables most predictive of one-year mortality.
Although estimation for such models is relatively straight-
forward using commercially available software, selection of a
“best” prediction model and validation of that model are
much more subtle tasks. The investigators (10) used an
analytical approach in which the data were randomly di-
vided in two subsamples: the first being used for model
construction and estimation and the second for assessment
of performance of model predictors. To avoid adversely
affecting model performance by overfitting or from multi-
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colinearity, only a limited number of the variables most
highly associated with one-year mortality were kept. No
appreciable drop in the predictability (as measured by the
area under the receiver-operating characteristic curve) was
found when this set of “optimal” predictors was included in
a model constructed from the validation sample.
The analysis largely ignores errors arising from uncer-
tainty regarding the model specification. The multitude of
strong associations with mortality in the CCP dataset allows
for construction of numerous highly predictive models.
Although a single prediction model was selected, other
model specifications may be virtually indistinguishable in
terms of their predictability. Whether a model is specified
on subject-matter grounds or fitted in an iterative way (as
was done here), error due to this model uncertainty is likely
to be far worse than that arising from estimation of
regression coefficients (which the present validation method
found to be minimal).
A simple way of addressing the issue of model uncertainty
is to determine to what extent the performance of the “best”
model reported here is superior (in terms of predictability)
to some “reference” prediction model that contains only the
traditional risk factors for mortality. For example, it would
be of considerable interest if the discriminatory ability of the
proposed model for coronary heart disease (CHD) is con-
siderably greater than that of the model for CHD prediction
derived from the Framingham Study data, which include
age, gender, blood pressure, total cholesterol, high density
lipoprotein cholesterol, smoking and diabetes (11), although
it should be noted that the Framingham data did not deal
exclusively with elderly survivors of MI. In theory, use of
prediction models should be restricted to individuals who
resemble the population from which the models were
derived. However, reasonable accuracy in prediction has
been demonstrated in the past when the Framingham CHD
prediction equations were applied to diverse population
samples. With this in mind, the merit of the proposed
prediction model for risk stratification, although clearly
demonstrated in this analysis, may not represent a signifi-
cant improvement over prediction based on traditional risk
factors. Further analyses may settle this issue.
There are three findings of interest to the clinician: 1)
identification of prognostic predictors of mortality at one
year; 2) demonstration that the prediction model built on
the analysis has performed well; and 3) derivation of a risk
score and categorization of individuals into different levels
of risk. Because of the large sample size, bivariate analyses
have identified a large number of variables that have reached
nominal statistical significance. For the analytic and statis-
tical reasons outlined above, the investigators have wisely set
high levels of statistical significance to identify the most
influential variables—which would be expected to have
strong clinical association with the mortality at one year.
This has resulted in identification of those independent
predictive factors that reflect a combination of age, frail
physical condition, cardiac and other systemic co-
morbidities and impairment of cardiac function, and which
are particularly specific to this population of older individ-
uals. Of interest is the finding that the use of beta-blockers,
aspirin and cardiac procedures did not influence the statis-
tical levels of significance. One may ask whether or not
these interventions had conferred a worthwhile benefit in
reducing the risk of dying within one year in these individ-
uals. Examination of the bivariate comparisons shows that
these interventions were individually associated with a
significant survival advantage, but the influence of patient
selection bias for these interventions is likely to be very
strong. It is probable that the individuals who were more
likely to survive due to the absence of the physical frailty and
other co-morbidities were those more likely to receive these
interventions.
Furthermore, the influence of competing risk from the
systemic co-morbidities is particularly strong in this popu-
lation. For example, the in-hospital use of angiotensin-
converting enzyme inhibitors was found to be associated
with excess mortality, suggesting that these agents may have
been prescribed preferentially to those with heart failure,
which itself has a much greater negative impact on eventual
survival in this population than the positive beneficial effects
of the medication.
It is reassuring to find that the logistic regression model
has good model discrimination and that the performance of
the validation model was similar to the original prediction
model. Subject to the methodological concerns discussed
above, regarding errors arising from uncertainty in the
model specifications, it would appear that extrapolation of
the findings to a similar population would be appropriate
and valid. Given that the study sample is derived from a
large nationwide cohort of elderly subjects, all with a
diagnosis of acute MI, the relevance of extrapolating this
model to similar patients would be much greater than the
corresponding models in many other studies.
A risk score, ranging from 0 to 13, was formulated based
on the final prediction Cox regression model, and weights
were assigned to each risk factor according to the magnitude
of the risk ratios derived from the Cox regression analysis.
By calculating the scores for individual patients and assign-
ing them into risk categories, the model was able to identify
a low-risk group with a 7%, a medium-risk group with a
24% and a high-risk group with a 49% one-year mortality.
Similar useful risk stratification findings were also obtained
for the combined end points of death plus rehospitalization
and death from acute MI plus rehospitalization. The use-
fulness of such a score is obvious and may prove to be the
major contribution of this study to clinical practice.
Many studies have reported on risk stratification of
patients with MI. An example is a comprehensive review of
risk stratification of hospitalized acute MI patients by
Peterson et al. (5). A timely and ongoing process of risk
stratification of the patient immediately at presentation to
the hospital with suspected MI is logical in order that
reperfusion therapy and other emergency care can be given
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without delay. Patients identified at high risk can be further
triaged to receive early angiography and other appropriate
interventions, whereas those at low risk for recurrent events
may be evaluated with noninvasive stress testing for further
risk stratification. Other studies have focused on elements of
risk stratification by using various noninvasive techniques
(1–3). Yet other studies attempted to identify risk factors
associated with long-term morbidity and mortality of sur-
vivors of acute MI (7–9). It might not be surprising that
results of these studies do not always agree, because of
differences in patient characteristics, choice and definition of
study end points, inclusion of various identified risk factors,
statistical power and other variables in the analyses (12).
This study by Krumholz et al. (10) is unique in several
respects. In addition to dealing exclusively with an elderly
population using a large sample size obtained on a nation-
wide scale, this study placed a greater emphasis on clinical
variables and identified a number of variables not usually
included in other studies, but it did not deal with issues
directly related to the early phase of the index MI. The
variables selected in such a geriatric population appropri-
ately included those on indices of frailty such as decreased
functional status and low body mass index, which have been
known in geriatric medicine as indicators of increased
mortality risk. By combining these clinical markers of risk
with a measure of cardiac function (left ventricular ejection
fraction [LVEF]) and the presence or absence of other
systematic diseases, which can have a large influence on
outcomes, the investigators have formulated what appears to
be a useful and practical risk prediction model. This is a
model that clinicians would be able to apply to their patients
without having to resort to sophisticated equipment and
tests for risk stratification.
However, the fact that this study did not include the
commonly used indices of subsequent cardiac risks, and that
the use of interventions such as beta-blockers, aspirin and
cardiac procedures did not materially affect the statistical
levels of significance may be causes for concern. Other than
including LVEF, this study has not included such conven-
tional predictors of risk as infarct characteristics, extent of
coronary disease, myocardium at risk for recurrent ischemia,
and electrocardiographic and other noninvasive markers of
ischemia. Thus, it is not clear whether inclusion of these
variables would improve upon the predictive utility of the
variables already included in this study.
On the one hand, it can be argued that this noninclusion
is a major flaw of this study and that inclusion of tests results
on these variables would clearly improve the study. On the
other hand, it may well be that, similar to the effects of
interventions such as beta-blockers, aspirin and cardiac
procedures, inclusion of these test results might not mate-
rially change the statistical significance, given the predom-
inant influence of the competing risks from the other
systemic co-morbidities commonly found in this popula-
tion. It is possible that both the impact of the conventional
risk predictors of cardiac function and myocardial ischemia
and the use of proven efficacious therapies, which have not
been addressed in this study, are of lesser importance in this
population. However, the usefulness of these diagnostic and
therapeutic strategies has been shown in the general popu-
lation, and there is no plausible reason that the elderly
population would not benefit from similar and appropriate
approaches to treatment. Thus, the generally accepted
management strategies for postinfarction patients should be
applied appropriately, taking into account the individual
patient’s potential to benefit or not to benefit from these
strategies. What this study emphasizes, however, is that
other information, particularly that on other noncardiac
co-morbidities, which are much more specific to this elderly
population, should be included in the decision-making
process.
As with all retrospective database analyses, the Krumholz
et al. (10) study suffers from the problem of missing data.
The most conspicuous of the missing data are LVEF (30%),
albumin (27%) and body mass index (15%). Left ventricular
ejection fraction and body mass index have been found to be
important independent risk predictors in this analysis, and
there is always a concern that the absence of these variables
in so many patients may affect the final results. It is quite
possible that the missing data were not random and that
these measurements were preferentially not obtained in
much sicker and frail patients. If this is the case, the impact
of the missing data might have important implications as to
the precision of the estimates. The investigators have tried
to overcome some of the deficiencies by using accepted
statistical methods. It is also reassuring to find that, in the
evaluation of performance of the prediction regression
model, analysis of outcomes on only those patients with
known ejection fractions showed the same high degree of
model discrimination.
Thus, the inclusion of predictive variables consisting
mainly of clinical and routine laboratory variables (and
minimum need for sophisticated assessment of cardiac
function and myocardial ischemia) in a large nationwide
population makes the extrapolation of these results practical
and useful in a widespread variety of clinical and health care
settings. By applying the risk score and risk categorization to
individual patients, clinicians can get a sense of the risk level
of subsequent one-year mortality and morbidity in their
patients and use this information as a basis for making
further diagnostic and therapeutic decisions. By including
the presence or absence of other systemic co-morbidities
into the consideration of risk quantitatively, a more realistic
expectation of treatment and outcomes can be obtained.
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